Analyst: Buy Biotech (IBB) On The Next Pullback

biotech-medical-pills
From David Dutkewych: Three weeks ago, I wrote about money pouring into U.S. stocks, specifically technology stocks. Now, just three weeks later, the high-flying tech sector is writing a different story.
NASDAQ:IBB June 23, 2017 6:51am

Examining The SPDR S&P Biotech ETF (XBI) Bullish Breakout

biotech-white-pills
From Chris Kimble: Biotech used to be an upside leader over the broad market coming off the 2009 lows. Biotech then officially gave up its leadership back in 2015, where it peaked and started underperforming the broad market.
NYSE:XBI June 22, 2017 6:37am

What’s Next For Biotech Stocks? (IBB)

biotech-white-pills
From Franklin Templeton Investments: Changing political policies and priorities can impact certain market sectors—for better or worse. Health care costs and prescription drug pricing were hot-button issues in the United States during the 2016 presidential election, and the Trump administration has been pushing forward its own health care agenda.
NASDAQ:IBB June 7, 2017 5:57am

Biotech Firms, NIH Team Up To Stop Trump’s Research Budget Cuts

biotech-medical-pills
The CEOs of several prominent biotech companies joined forces with the head of the National Institutes of Health (NIH) today in Washington to try and convince the White House not to seek major budget reductions for medical research.
NASDAQ:IBB May 8, 2017 4:17pm

Will Biotech Bulls Or Bears Blink First?

leverage bull bear 600X300
From Taki Tsaklanos: Stock market indexes gain around 1 percent on Thursday. The small cap index Russell 2000 rose around of 1.15%, making it the best performing U.S. stock market index of the day.
NASDAQ:IBB April 21, 2017 6:21am

New Month Brings Fresh Outflows In Small Cap Funds Once Again

smallcap
Analyst Paul Weisbruch of Street One Financial brings us his daily fund flows update, which today picks up on renewed selling of small cap funds, along with some apparent sector rotation into energy and away from a few other sectors.
NYSE:IWM April 5, 2017 12:40pm

BlackRock: Opportunities Abound In Biotech, Healthcare

biotech-white-pills
From BlackRock: A dynamic of haves versus have-nots means that health care is increasingly all about stock picking. Kate Moore sees opportunities in biotech, medical devices, U.S. managed care and selected big pharma with promising drug pipelines.
NASDAQ:IBB April 3, 2017 7:26am

This Tiny Early-Stage Biotech ETF Was Q1’s Best Performing Fund

biotech-dna
From Zacks: After being stressed by the twin attacks of higher drug pricing and increased regulatory scrutiny, the biotech sector has made a strong comeback in the first quarter of 2017.
NASDAQ:BBC March 31, 2017 9:38am

These Sector ETFs Are Looking Pretty Bearish Right Now

bear-mkt
From David Fabian: I’m normally an optimistic, “glass-half-full” kind of guy. I roll my eyes every time I see a headline decrying the next market crash or cataclysmic event that will cripple the global economy. I’m quick to discern speculation from truths and prefer taking the opposite side of most mainstream assumptions.
NASDAQ:IBB March 23, 2017 6:26am

Here Are The Best Performing ETFs Of 2017 Thus Far

momentum-up
From Moby Waller: A huge amount of money goes into passive stock market tracking these days, through the S&P 500 Index (SPY) and other major U.S. indexes (DIA) (QQQ) (IWM). This strategy has done well in general in recent years and has gained popularity, particularly in retirement-type accounts.
NYSE:XBI March 17, 2017 6:21am

Have Biotech ETFs Finally Bottomed?

biotech-white-pills
From Zacks: 2016 was a tough year for biotech stocks with the sector facing a lot of criticism for rising drug prices. Although shares did rally post-election in November on hopes that drug pricing would not be a key focus area under a Donald Trump presidency, the rally turned out to be short-lived following the President’s views regarding drug pricing.
NASDAQ:IBB March 14, 2017 7:54am

Why The $300 Level Is So Important For The Biotech ETF

biotech-dna
From Taki Tsaklanos: Biotechnology stocks are breaking out. They have been consolidating for nearly 20 months. Investors lost interest...and that is exactly what smart investors, in general, want to see in order to buy a market.
NASDAQ:IBB March 3, 2017 6:13am

Analyst: Big Opportunities Coming In Medical Device Space

Medical Device
From The Gold Report: The stage has been set for high levels of uncertainty, and with uncertainty comes opportunities in commodities, posits Lior Gantz, editor of Wealth Research Group, who also sees opportunities in disruptive technologies in the medical arena.
NYSE:XHE February 24, 2017 7:45am

This Biotech ETF Looks Primed To Rally Again

biotech-white-pills
The biotech sector has gotten a lot of attention lately both in the financial markets and in Washington. The sector, which was one of the worst performing areas of the market in 2016 posting a loss of more than 20%, has started posting gains again and is looking like the rally may be poised to continue.
NASDAQ:IBB February 20, 2017 6:42am

Recommended for You

Explore More from ETFDailyNews.com

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again!

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories